Zijian Feng to Humans
This is a "connection" page, showing publications Zijian Feng has written about Humans.
Connection Strength
0.074
-
Comprehensive large-scale nucleic acid-testing strategies support China's sustained containment of COVID-19. Nat Med. 2021 05; 27(5):740-742.
Score: 0.008
-
Risk factors for developing severe COVID-19 in China: an analysis of disease surveillance data. Infect Dis Poverty. 2021 Apr 12; 10(1):48.
Score: 0.008
-
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 03 26; 382(13):1199-1207.
Score: 0.007
-
Clusters of Human Infections With Avian Influenza A(H7N9) Virus in China, March 2013 to June 2015. J Infect Dis. 2017 09 15; 216(suppl_4):S548-S554.
Score: 0.006
-
The knowledge, attitudes and practices on influenza among medical college students in Northwest China. Hum Vaccin Immunother. 2017 07 03; 13(7):1688-1692.
Score: 0.006
-
Characterization of hand, foot, and mouth disease in China between 2008 and 2009. Biomed Environ Sci. 2011 Jun; 24(3):214-21.
Score: 0.004
-
Gaps remain in China's ability to detect emerging infectious diseases despite advances since the onset of SARS and avian flu. Health Aff (Millwood). 2011 Jan; 30(1):127-35.
Score: 0.004
-
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 to Close Contacts, China, January-February 2020. Emerg Infect Dis. 2021 09; 27(9):2288-2293.
Score: 0.002
-
Impact of COVID-19 outbreaks and interventions on influenza in China and the United States. Nat Commun. 2021 05 31; 12(1):3249.
Score: 0.002
-
Risk factors and on-site simulation of environmental transmission of SARS-CoV-2 in the largest wholesale market of Beijing, China. Sci Total Environ. 2021 Jul 15; 778:146040.
Score: 0.002
-
Asymptomatic SARS-CoV-2 Infections Among Persons Entering China From April 16 to October 12, 2020. JAMA. 2021 02 02; 325(5):489-492.
Score: 0.002
-
One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China. Clin Infect Dis. 2021 01 27; 72(2):332-339.
Score: 0.002
-
Time Course of a Second Outbreak of COVID-19 in Beijing, China, June-July 2020. JAMA. 2020 10 13; 324(14):1458-1459.
Score: 0.002
-
Evidence for pre-symptomatic transmission of coronavirus disease 2019 (COVID-19) in China. Influenza Other Respir Viruses. 2021 01; 15(1):19-26.
Score: 0.002
-
Active case finding with case management: the key to tackling the COVID-19 pandemic. Lancet. 2020 07 04; 396(10243):63-70.
Score: 0.002
-
Lessons from an active surveillance pilot to assess the pneumonia of unknown etiology surveillance system in China, 2016: the need to increase clinician participation in the detection and reporting of emerging respiratory infectious diseases. BMC Infect Dis. 2019 Sep 03; 19(1):770.
Score: 0.002
-
Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. BMC Cancer. 2019 Jun 25; 19(1):622.
Score: 0.002
-
Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14-14-2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial. Lancet Infect Dis. 2019 04; 19(4):402-409.
Score: 0.002
-
Expression of activator protein-1 in papillary thyroid carcinoma and its clinical significance. World J Surg Oncol. 2019 Jan 31; 17(1):25.
Score: 0.002
-
Epidemiological profile and progress toward rubella elimination in China. 10 years after nationwide introduction of rubella vaccine. Vaccine. 2018 04 12; 36(16):2079-2085.
Score: 0.002
-
Clusters of Human Infection and Human-to-Human Transmission of Avian Influenza A(H7N9) Virus, 2013-2017. Emerg Infect Dis. 2018 02; 24(2).
Score: 0.002
-
Preliminary Epidemiology of Human Infections with Highly Pathogenic Avian Influenza A(H7N9) Virus, China, 2017. Emerg Infect Dis. 2017 08; 23(8):1355-1359.
Score: 0.001
-
Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China. Emerg Infect Dis. 2017 05; 23(5):765-772.
Score: 0.001
-
Describing interaction effect between lagged rainfalls on malaria: an epidemiological study in south-west China. Malar J. 2017 01 31; 16(1):53.
Score: 0.001
-
Sudden increase in human infection with avian influenza A(H7N9) virus in China, September-December 2016. Western Pac Surveill Response J. 2017 Jan-Mar; 8(1):6-14.
Score: 0.001
-
Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above. Hum Vaccin Immunother. 2017 01 02; 13(1):144-150.
Score: 0.001
-
Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013 May 16; 368(20):1888-97.
Score: 0.001
-
Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet. 2006 Sep 16; 368(9540):991-7.
Score: 0.001